Measuring social communication behaviors as a treatment endpoint in individuals with autism spectrum disorder

被引:149
作者
Anagnostou, Evdokia [1 ]
Jones, Nancy [2 ]
Huerta, Marisela [3 ]
Halladay, Alycia K. [4 ]
Wang, Paul [4 ]
Scahill, Lawrence [5 ]
Horrigan, Joseph P. [2 ]
Kasari, Connie [6 ]
Lord, Cathy [3 ]
Choi, Dennis [7 ]
Sullivan, Katherine [8 ]
Dawson, Geraldine [9 ]
机构
[1] Univ Toronto, Holland Bloorview Kids Rehabil Hosp, Toronto, ON M4G 1R8, Canada
[2] Neuren Pharmaceut Ltd, New York, NY USA
[3] Weill Cornell Med Coll, New York, NY USA
[4] Autism Speaks, New York, NY USA
[5] Emory Univ, Atlanta, GA 30322 USA
[6] Univ Calif Los Angeles, Los Angeles, CA USA
[7] SUNY Stony Brook, Stony Brook, NY USA
[8] New York Presbyterian Hosp, Weill Cornell Med Ctr, New York, NY USA
[9] Duke Univ, Durham, NC 27706 USA
关键词
autism spectrum disorders; behavioral measurement; outcome measures; social cognition and social behavior; HIGH-FUNCTIONING AUTISM; PERVASIVE DEVELOPMENTAL DISORDERS; RANDOMIZED CONTROLLED-TRIAL; CRITERION-RELATED VALIDITY; SKILLS GROUP INTERVENTION; ABERRANT-BEHAVIOR; JOINT ATTENTION; NONVERBAL-COMMUNICATION; DIAGNOSTIC INTERVIEW; ADAPTIVE-BEHAVIOR;
D O I
10.1177/1362361314542955
中图分类号
B844 [发展心理学(人类心理学)];
学科分类号
040202 ;
摘要
Social communication impairments are a core deficit in autism spectrum disorder. Social communication deficit is also an early indicator of autism spectrum disorder and a factor in long-term outcomes. Thus, this symptom domain represents a critical treatment target. Identifying reliable and valid outcome measures for social communication across a range of treatment approaches is essential. Autism Speaks engaged a panel of experts to evaluate the readiness of available measures of social communication for use as outcome measures in clinical trials. The panel held monthly conference calls and two face-to-face meetings over 14months. Key criteria used to evaluate measures included the relevance to the clinical target, coverage of the symptom domain, and psychometric properties (validity and reliability, as well as evidence of sensitivity to change). In all, 38 measures were evaluated and 6 measures were considered appropriate for use, with some limitations. This report discusses the relative strengths and weaknesses of existing social communication measures for use in clinical trials and identifies specific areas in need of further development.
引用
收藏
页码:622 / 636
页数:15
相关论文
共 151 条
  • [1] Effect of a vitamin/mineral supplement on children and adults with autism
    Adams, James B.
    Audhya, Tapan
    McDonough-Means, Sharon
    Rubin, Robert A.
    Quig, David
    Geis, Elizabeth
    Gehn, Eva
    Loresto, Melissa
    Mitchell, Jessica
    Atwood, Sharon
    Barnhouse, Suzanne
    Lee, Wondra
    [J]. BMC PEDIATRICS, 2011, 11
  • [2] Double-blind placebo-controlled trial of pentoxifylline added to risperidone: Effects on aberrant behavior in children with autism
    Akhondzadeh, Shahin
    Fallah, Jalil
    Mohammadi, Mohammad-Reza
    Imani, Reza
    Mohammadi, Mohammad
    Salehi, Bahman
    Ghanizadeh, Ahmad
    Raznahan, Maedeh
    Mohebbi-Rasa, Soodeh
    Rezazadeh, Shams-Ali
    Forghani, Saeedeh
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2010, 34 (01) : 32 - 36
  • [3] Aman MG, 2005, ARCH GEN PSYCHIAT, V62, P1266
  • [4] AMAN MG, 1995, AM J MENT RETARD, V100, P283
  • [5] AMAN MG, 1985, AM J MENT DEF, V89, P492
  • [6] AMAN MG, 1985, AM J MENT DEF, V89, P485
  • [7] Promoting social behavior with oxytocin in high-functioning autism spectrum disorders
    Andari, Elissar
    Duhamel, Jean-Rene
    Zalla, Tiziana
    Herbrecht, Evelyn
    Leboyer, Marion
    Sirigu, Angela
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (09) : 4389 - 4394
  • [8] [Anonymous], 2010, REMEDIAL SPECIAL ED
  • [9] [Anonymous], INT PEDIAT
  • [10] [Anonymous], COMP BASC 2 BASC PRS